Journals LibraryNHS NIHR - National Institute for Health Research
HTA - 95/13/01
A randomised controlled trial of longer-term clinical outcomes and cost-effectiveness of standard and new antiepileptic drugs (SANAD)
Project title: A randomised controlled trial of longer-term clinical outcomes and cost-effectiveness of standard and new antiepileptic drugs (SANAD)
Call to action: 95/13 New antiepileptic drugs and existing therapies
Research type: Primary Research
Chief investigator: Professor David Chadwick
Contractor: University of Liverpool
Started: September 1998 | Status: Published October 2007
Trial provides evidence that lamotrigine may be a clinical and cost-effective alternative to the existing standard drug treatment, carbamazepine, for epilepsy patients diagnosed as having partial seizures.
Links to project documentation
The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.